Search Results - "Woll, J."

Neurocognitive deficits in depression: a systematic review of cognitive impairment in the acute and remitted state by Kriesche, Dominik, Woll, Christian F. J., Tschentscher, Nadja, Engel, Rolf R., Karch, Susanne

“…Previous research suggests a broad range of deficits in major depressive disorder. Our goal was to update the current assumptions and investigate the extent of…”
Get full text

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial by Faivre-Finn, Corinne, Prof, Snee, Michael, DM, Ashcroft, Linda, MSc, Appel, Wiebke, MD, Barlesi, Fabrice, Prof, Bhatnagar, Adityanarayan, MD, Bezjak, Andrea, MD, Cardenal, Felipe, PhD, Fournel, Pierre, Prof, Harden, Susan, DM [Oxon], Le Pechoux, Cecile, MD, McMenemin, Rhona, MSc, Mohammed, Nazia, FRCR, O'Brien, Mary, MD, Pantarotto, Jason, MD, Surmont, Veerle, Prof, Van Meerbeeck, Jan P, Prof, Woll, Penella J, Prof, Lorigan, Paul, Prof, Blackhall, Fiona, Prof

“…Summary Background Concurrent chemoradiotherapy is the standard of care in limited-stage small-cell lung cancer, but the optimal radiotherapy schedule and dose…”
Get full text

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma by HENRY, David H, COSTA, Luis, VON MOOS, Roger, WILLENBACHER, Wolfgang, WOLL, Penella J, JIANMING WANG, QI JIANG, SUSIE JUN, DANSEY, Roger, YEH, Howard, GOLDWASSER, Francois, HIRSH, Vera, HUNGRIA, Vania, PRAUSOVA, Jana, SCAGLIOTTI, Giorgio Vittorio, SLEEBOOM, Harm, SPENCER, Andrew, VADHAN-RAJ, Saroj

“…This study compared denosumab, a fully human monoclonal anti-receptor activator of nuclear factor kappa-B ligand antibody, with zoledronic acid (ZA) for…”
Get full text

Angiosarcoma by Young, Robin J, Dr, Brown, Nicola J, Prof, Reed, Malcolm W, Prof, Hughes, David, FRCPath, Woll, Penella J, Prof

“…Summary Angiosarcomas are rare soft-tissue sarcomas of endothelial cell origin that have a poor prognosis. They can arise anywhere in the body, most commonly…”
Get full text

Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium by Zhang, Li Rita, Morgenstern, Hal, Greenland, Sander, Chang, Shen‐Chih, Lazarus, Philip, Teare, M. Dawn, Woll, Penella J., Orlow, Irene, Cox, Brian, Brhane, Yonathan, Liu, Geoffrey, Hung, Rayjean J.

“…To investigate the association between cannabis smoking and lung cancer risk, data on 2,159 lung cancer cases and 2,985 controls were pooled from 6…”
Get full text

Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial by Woll, Penella J, Prof, Reichardt, Peter, MD, Le Cesne, Axel, MD, Bonvalot, Sylvie, MD, Azzarelli, Alberto, MD, Hoekstra, Harald J, Prof, Leahy, Michael, FRCP, Van Coevorden, Frits, MD, Verweij, Jaap, Prof, Hogendoorn, Pancras CW, Prof, Ouali, Monia, MSc, Marreaud, Sandrine, MD, Bramwell, Vivien HC, Prof, Hohenberger, Peter, Prof

“…Summary Background The effect of adjuvant chemotherapy on survival for resected soft-tissue sarcoma remains unknown. We investigated the effect of intensive…”
Get full text

First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: Pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials by Young, R.J, Natukunda, A, Litière, S, Woll, P.J, Wardelmann, E, van der Graaf, W.T.A

“…Abstract Background Angiosarcoma is a rare subtype of soft tissue sarcoma (STS). Doxorubicin is the standard first-line chemotherapy for advanced STS. It is…”
Get full text

First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial by Lee, Siow Ming, Prof, Khan, Iftekhar, MSc, Upadhyay, Sunil, MD, Lewanski, Conrad, FRCP, Falk, Stephen, MD, Skailes, Geraldine, FRCR, Marshall, Ernie, MD, Woll, Penella J, Prof, Hatton, Matthew, FRCR, Lal, Rohit, MRCP, Jones, Richard, FRCR, Toy, Elizabeth, FRCR, Chao, David, DPhil, Middleton, Gary, MD, Bulley, Sue, SRN, Ngai, Yenting, BSc, Rudd, Robin, MD, Hackshaw, Allan, Prof, Boshoff, Chris, Prof

“…Summary Background Many patients with advanced non-small-cell lung cancer (NSCLC) receive only active supportive care because of poor performance status or…”
Get full text

Optimizing the yield and utility of circulating cell-free DNA from plasma and serum by Xue, Xiaoyan, Teare, M. Dawn, Holen, Ingunn, Zhu, Yong M., Woll, Penella J.

“…Cell-free DNA (CFDNA) in the plasma/serum of patients with cancer demonstrates tumour-associated genetic alterations, offering possibilities for diagnosis,…”
Get full text

Overcoming CYP1A1/1A2 Mediated Induction of Metabolism by Escalating Erlotinib Dose in Current Smokers by HUGHES, Andrew N, O'BRIEN, Mary E. R, PRICE, Allan, PETTY, W. Jeffrey, CHICK, Jonathan B, RANKIN, Elaine, WOLL, Penella J, DUNLOP, David, NICOLSON, Marianne, BOINPALLY, Ramesh, WOLF, Julie

“…Cigarette smoking induces CYP1A1/1A2 and is hypothesized to alter erlotinib pharmacokinetics. This study aimed to determine the maximum tolerated dose (MTD) of…”
Get full text

Neurocognitive Deficits in First-Episode and Chronic Psychotic Disorders: A Systematic Review from 2009 to 2022 by Tschentscher, Nadja, Woll, Christian F J, Tafelmaier, Julia C, Kriesche, Dominik, Bucher, Julia C, Engel, Rolf R, Karch, Susanne

“…Cognitive impairment in patients suffering from schizophrenia spectrum disorders has been discussed as a strong predictor for multiple disease outcome…”
Get full text

Bipolar vessel-sealing devices in laparoscopic hysterectomies: a multicenter randomized controlled clinical trial by Hasanov, M., Denschlag, D., Seemann, E., Gitsch, G., Woll, J., Klar, Maximilian

“…Objective To compare operating time and blood loss in patients undergoing total laparoscopic hysterectomies (TLH) for benign conditions with either the…”
Get full text

Randomized Double-Blind Placebo-Controlled Trial of Thalidomide in Combination With Gemcitabine and Carboplatin in Advanced Non–Small-Cell Lung Cancer by MINGLEE, Siow, RUDD, Robin, WOLL, Penella J, OTTENSMEIER, Christian, GILLIGAN, David, PRICE, Allan, SPIRO, Stephen, GOWER, Nicole, JITLAL, Mark, HACKSHAW, Allan

“…Cancers rely on angiogenesis for their growth and dissemination. We hypothesized that thalidomide, an oral antiangiogenic agent, when combined with…”
Get full text

The Clinical Impact of Real-Time fMRI Neurofeedback on Emotion Regulation: A Systematic Review by Tschentscher, Nadja, Tafelmaier, Julia C, Woll, Christian F J, Pogarell, Oliver, Maywald, Maximilian, Vierl, Larissa, Breitenstein, Katrin, Karch, Susanne

“…Emotion dysregulation has long been considered a key symptom in multiple psychiatric disorders. Difficulties in emotion regulation have been associated with…”
Get full text

Vascular-targeted agents for the treatment of angiosarcoma by Young, R. J., Woll, P. J., Staton, C. A., Reed, M. W. R., Brown, N. J.

“…Purpose Angiosarcomas are rare, aggressive vascular tumours known to express vascular endothelial growth factor (VEGF), a key pro-angiogenic growth factor. The…”
Get full text

The use of bisphosphonates in the management of bone involvement from solid tumours and haematological malignancies – a European survey by Lebret, T., Casas, A., Cavo, M., Woll, P.J., Deleplace, C., Kennedy, C., Schoen, P., Jackisch, C.

“…Bone metastases in patients with solid tumours (ST) and bone lesions in patients with haematological malignancies (HM) are common. Associated skeletal‐related…”
Get full text

Bone-targeted agents in the treatment of lung cancer by Silva, Shobha C., Wilson, Caroline, Woll, Penella J.

“…Over a third of patients with lung cancer will develop bone metastases during the course of their disease, resulting in symptoms of pain and immobility, and…”
Get full text

Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide by Young, R J, Tin, A W, Brown, N J, Jitlal, M, Lee, S M, Woll, P J

“…Background: Thalidomide has potent anti-inflammatory and anti-angiogenic properties. It was evaluated in combination with chemotherapy in two randomised…”
Get full text

Production and upregulation of granulocyte chemotactic protein-2/CXCL6 by IL-1β and hypoxia in small cell lung cancer by ZHU, Y. M, BAGSTAFF, S. M, WOLL, P. J

“…Small cell lung cancer (SCLC) is characterised by early and widespread metastasis. However, SCLC cells have so far been found to produce low levels of known…”
Get full text

Interleukin-8 CXCL8 is a growth factor for human lung cancer cells by ZHU, Y. M, WEBSTER, S. J, FLOWERY, D, WALL, P. J

“…Interleukin-8/CXCL8 (IL-8) is a chemokine and angiogenic factor. Recently, IL-8 was identified as an autocrine growth factor in several human cancers. Here, we…”
Get full text